Dec 19 Love0 The End of the Black Box Warning: How the FDA’s 2025 HRT Regulatory Shift Redefines Patient Access By Dr. Samuel Thornton Testosterone Replacement Therapy A Label Change Does Not Replace Individual Risk Review Why the 2025 FDA shift changes the conversation around menopausal hormone therapy without removing the need for careful screening How timing, formulation, and route…Read More